Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. SHORT...
We first recommended $ACST to our subscribers when it was trading at $1.01 a share. Many missed the exit and are still asking what levels to trade $ACST off of. The fibonacci retracement levels provide a good indicator to go off. Good luck to all!
Since breaking-out last October'18, ACASTI PHARMA INC - NASDAQ:ACST has been trading in a side-ways grind with no real progress towards higher levels to speak of. However, we've been monitoring the action closely for some time now and it appears that ACST may just be starting to pick its head up as evidenced in the Daily chart above. With the stock trading...
ACST broke upward passed our MA, it is between a major support and resistance line. Way to early to call a buy or sell. the next few days will be key. if says above the support we will take a position and target 5% easy
Fib time zones align -#connect4 major- bounce later minor(dead-bounce-fall--*bounce) pattern made@ \90,120,160--=90 drop with another 90 bounce/160, $precidtion